Clinical trial of creatine for Parkinson's disease

Armen Hareyan's picture
Advertisement

The University of Michigan Health System will participate in a large-scale national clinical trial to learn if the nutritional supplement creatine can slow the progression of Parkinson's disease. While creatine is not an approved therapy for PD or any other condition, it is widely thought to improve exercise performance.

Advertisement

The potential benefit of creatine for PD was identified by Parkinson's researchers through a new rapid method for screening potential compounds. The trial, which begins today, is sponsored by the National Institutes of Health (NIH).

The double-blind, placebo-controlled, phase III study is one of the largest PD clinical trials to date. UMHS is one of 51 medical centers in the United States and Canada

Advertisement